RC-3095, a Selective Gastrin-Releasing Peptide Receptor Antagonist, Does Not Protect the Lungs in an Experimental Model of Lung Ischemia-Reperfusion Injury

<div>IL-1<i>β</i> and TNF-<i>α</i> protein expression. There was no significant differences in lung tissue protein expression among the groups in IL-1<i>β</i> (<i>P</i> = 0.159) and TNF-<i>α</i> (<i>P</i> = 0.260). Data are presented as median ± standard error of the median.</div>

BioMed Research International

fig1

Figure 1

Figure 1: RC-3095, a Selective Gastrin-Releasing Peptide Receptor Antagonist, Does Not Protect the Lungs in an Experimental Model of Lung Ischemia-Reperfusion Injury 

Figure 1 | RC-3095, a Selective Gastrin-Releasing Peptide Receptor Antagonist, Does Not Protect the Lungs in an Experimental Model of Lung Ischemia-Reperfusion Injury 